"Medical Benefit" and Therapeutic Misconception: The Ethical Conundrum of Phase 1 Pediatric Oncology Research

Affiliations

¹ Department of Medical Humanities and Bioethics, University of Arkansas Medical Sciences, Little Rock, Arkansas.
² Department of Pediatrics, University of Chicago, Chicago, Illinois.

Editorial

D Micah Hester et al. J Pediatr. 2021 Nov.

. 2021 Nov:238:11-13.

doi: 10.1016/j.jpeds.2021.06.081. Epub 2021 Jul 3.

¹ Department of Medical Humanities and Bioethics, University of Arkansas Medical Sciences, Little Rock, Arkansas.
² Department of Pediatrics, University of Chicago, Chicago, Illinois.

No abstract available

Keywords: benefit; ethics; pediatric research; phase 1 research; therapeutic misconception.

Comment on

Do the Potential Medical Benefits of Phase 1 Pediatric Oncology Trials Justify the Risks? Views of the United States Public.
Schupmann W, Li X, Wendler D. Schupmann W, et al. J Pediatr. 2021 Nov;238:249-258.e3. doi: 10.1016/j.jpeds.2021.06.009. Epub 2021 Jun 16. J Pediatr. 2021. PMID: 34144034 Free PMC article.